Inherited Thrombophilia: Key Points for Genetic Counseling

Overview

Journal J Genet Couns

Publisher Wiley

Specialty Genetics

Date 2007 May 3

PMID 17473965

Citations 4

Authors

Elizabeth Varga

Affiliations

Soon will be listed here.

Abstract

With the evolution of medical genetics to focus on highly prevalent, multifactorial conditions, it is inevitable that genetic counselors will be called upon to participate in the evaluation and counseling of individuals with inherited thrombophilia. The purpose of this review is to educate the genetic counselor on key issues related to risk assessment and genetic counseling for hereditary thrombophilia. The information contained in this document is derived from an extensive review of the literature, as well as the author's personal expertise. Upon completion of this review, the genetic counselor will be able to: a) describe inherited and acquired risk factors for thrombosis, b) collect and interpret personal and family histories to assess risk related to hereditary thrombophilia, c) discuss the potential advantages and disadvantages of thrombophilia testing, including psychosocial aspects and implications for medical management, and d) identify educational and support resources for patients and families.

Citing Articles

COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis.

Pomara C, Sessa F, Ciaccio M, Dieli F, Esposito M, Giammanco G Diagnostics (Basel). 2021; 11(6).

PMID: 34073536 PMC: 8229116. DOI: 10.3390/diagnostics11060955.

Combined presence of coagulation factor XIII V34L and plasminogen activator inhibitor 1 4G/5G gene polymorphisms significantly contribute to recurrent pregnancy loss in Serbian population.

Joksic I, Mikovic Z, Filimonovic D, Munjas J, Karadzov O, Egic A J Med Biochem. 2020; 39(2):199-207.

PMID: 33033453 PMC: 7526018. DOI: 10.2478/jomb-2019-0028.

A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing.

Berg J, Foreman A, ODaniel J, Booker J, Boshe L, Carey T Genet Med. 2015; 18(5):467-75.

PMID: 26270767 PMC: 4752935. DOI: 10.1038/gim.2015.104.

Genetic counseling for inherited thrombophilias.

Varga E J Thromb Thrombolysis. 2007; 25(1):6-9.

PMID: 17952558 DOI: 10.1007/s11239-007-0056-2.

References

Bonaa K, Njolstad I, Ueland P, Schirmer H, Tverdal A, Steigen T . Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006; 354(15):1578-88. DOI: 10.1056/NEJMoa055227. View

Middeldorp S, Henkens C, Koopman M, van Pampus E, Hamulyak K, van der Meer J . The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med. 1998; 128(1):15-20. DOI: 10.7326/0003-4819-128-1-199801010-00003. View

Ridker P, Miletich J, Hennekens C, Buring J . Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 1997; 277(16):1305-7. View

Brill-Edwards P, Ginsberg J, Gent M, Hirsh J, Burrows R, Kearon C . Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med. 2000; 343(20):1439-44. DOI: 10.1056/NEJM200011163432002. View

Bates S, Greer I, Hirsh J, Ginsberg J . Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 Suppl):627S-644S. DOI: 10.1378/chest.126.3_suppl.627S. View

. College of American Pathologists Consensus Conference XXXVI: Diagnostic Issues in Thrombophilia. Arch Pathol Lab Med. 2002; 126(11):1277-433. DOI: 10.5858/2002-126-1277-COAPCC. View

. ACOG Practice Bulletin #68: Antiphospholipid syndrome. Obstet Gynecol. 2005; 106(5 Pt 1):1113-21. DOI: 10.1097/00006250-200511000-00056. View

Martinelli I, Taioli E, Bucciarelli P, Akhavan S, Mannucci P . Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol. 1999; 19(3):700-3. DOI: 10.1161/01.atv.19.3.700. View

Press R, Bauer K, Kujovich J, Heit J . Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med. 2002; 126(11):1304-18. DOI: 10.5858/2002-126-1304-CUOFVL. View

10.

Wu O, Robertson L, Twaddle S, Lowe G, Clark P, Walker I . Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol. 2005; 131(1):80-90. DOI: 10.1111/j.1365-2141.2005.05715.x. View

11.

Tait R, Walker I, Davidson J, Islam S, Mitchell R . Antithrombin III activity in healthy blood donors: age and sex related changes and prevalence of asymptomatic deficiency. Br J Haematol. 1990; 75(1):141-2. DOI: 10.1111/j.1365-2141.1990.tb02635.x. View

12.

Esfahani S, Cogger E, Caudill M . Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc. 2003; 103(2):200-7. DOI: 10.1053/jada.2003.50030. View

13.

Seligsohn U, Lubetsky A . Genetic susceptibility to venous thrombosis. N Engl J Med. 2001; 344(16):1222-31. DOI: 10.1056/NEJM200104193441607. View

14.

Nicolaides A, Breddin H, Carpenter P, Coccheri S, Conard J, De Stefano V . Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol. 2005; 24(1):1-26. View

15.

Tait R, Walker I, Reitsma P, Islam S, MCCALL F, Poort S . Prevalence of protein C deficiency in the healthy population. Thromb Haemost. 1995; 73(1):87-93. View

16.

Schambeck C, Schwender S, Haubitz I, Geisen U, Grossmann R, Keller F . Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?. Thromb Haemost. 1998; 78(6):1480-3. View

17.

Heit J, OFallon W, Petterson T, Lohse C, Silverstein M, Mohr D . Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002; 162(11):1245-8. DOI: 10.1001/archinte.162.11.1245. View

18.

Rosendaal F . Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program. 2005; :1-12. DOI: 10.1182/asheducation-2005.1.1. View

19.

Marlar R, Montgomery R, Broekmans A . Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S. Thromb Haemost. 1989; 61(3):529-31. View

20.

James A, Abel D, Brancazio L . Anticoagulants in pregnancy. Obstet Gynecol Surv. 2005; 61(1):59-69. DOI: 10.1097/01.ogx.0000193878.57208.ad. View